Related Experiment Videos
[Successful therapy with etanercept in relapsing polychondritis]
1Klinik für Innere Medizin und Rheumatologie, Fachklinik Bad Bentheim, 48455, Bad Bentheim, Deutschland.
Zeitschrift Fur Rheumatologie
|February 2, 2010
Summary
Relapsing polychondritis, a rare autoimmune cartilage disease, can be severe. Etanercept, a TNF-alpha-antagonist, effectively reduced disease activity in a challenging case.
Area of Science:
- Rheumatology
- Immunology
- Autoimmune Diseases
Background:
- Relapsing polychondritis (RP) is a rare systemic autoimmune disorder.
- RP is characterized by progressive inflammation and destruction of cartilaginous structures and connective tissues.
- Severe RP cases often present complex clinical courses resistant to conventional therapies.
Observation:
- A patient with severe relapsing polychondritis experienced a progressive disease course.
- Standard disease-modifying anti-rheumatic drugs (DMARDs) failed to adequately control the patient's condition.
- The patient's severe symptoms and complications necessitated exploring alternative therapeutic strategies.
Findings:
- Treatment with etanercept, a tumor necrosis factor-alpha (TNF-alpha) antagonist, was initiated.
- Etanercept therapy resulted in a significant reduction in relapsing polychondritis disease activity.
- This intervention demonstrated a positive clinical response in a refractory case.
Implications:
- This case provides further evidence supporting the efficacy of TNF-alpha antagonists in managing relapsing polychondritis.
- Targeting TNF-alpha may represent a viable therapeutic option for severe or refractory RP cases.
- Further research into biologic therapies for rare autoimmune cartilage diseases is warranted.
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:17Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...